About SNEC

Singapore National Eye Centre (SNEC) was incorporated in 1989 and commenced operations in 1990. It is the designated centre within the public sector healthcare network to spearhead and co-ordinate the provision of specialised ophthalmological services with emphasis on quality education and research.

Since its opening in 1990, SNEC has achieved rapid growth and currently manages an annual workload of 14,000 major eye surgeries and 13,000 laser procedures.

Nine subspecialties in Cataract and Comprehensive Ophthalmology, Cornea, Glaucoma, Neuro-Ophthalmology, Oculoplastic and Aesthetic Eyeplastic, Paediatric Ophthalmology and Strabismus, Refractive Surgery, Ocular Inflammation and Immunology Service and Vitro-Retina have been established to provide a full range of eye treatment from comprehensive to tertiary levels for the entire spectrum of eye conditions.

SNEC is actively involved in clinical trials and research into the causes and treatment of major eye conditions such as myopia and glaucoma. Thousands of ophthalmologists from neighbouring countries and beyond have participated in the Centre's teaching courses and international meetings organised annually. To advance ophthalmic science and service, and to increase opportunities for professional interactions and collaboration, SNEC has also fostered strategic links with leading eye institutions around the world.

To meet increasing demand for clinical service, teaching, research and international ophthalmic activities, SNEC has undergone expansion with its Phase 2 extension at a total cost of $50 million funded by the Government.

The new extension wing consists of a 8-storey building totaling 14,850 sq m encompassing 2 floors of outpatient clinics supported by comprehensive ancillary facilities, 5 new operating theatres with expanded day recovery suites, an auditorium and new resource centre, 2 floors to house the Singapore Eye Research Institute's research clinics and basic research laboratories as well as space for administrative offices.

The new Phase 2 wing will more than double the Centre's operating capacity and will further enhance SNEC's capabilities to deliver cost effective quality eye care to meet increasing demand and to expand its role in ophthalmic education and research.